<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="19623">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02851433</url>
  </required_header>
  <id_info>
    <org_study_id>JAUDON-FAIVRE 2014</org_study_id>
    <nct_id>NCT02851433</nct_id>
  </id_info>
  <brief_title>Evaluate the Protective Effect of Conditioning With Sevoflurane on the Myocardium</brief_title>
  <acronym>SUPRA</acronym>
  <official_title>Evaluate the Protective Effect of Conditioning With Sevoflurane Versus Propofol on the Myocardium in Scheduled Aortic Valve Replacement Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      Heart surgery is a considerable source of stress for the myocardium that must be minimized.

      Troponin Ic is a reliable marker to determine the level of this myocardial stress.

      Studies have shown that post-conditioning with AVH has a protective effect on the
      myocardium, if the treatment is initiated at the start of the ischemia.

      The aim of this study is to evaluate the protective effect on the myocardium (by measuring
      troponin levels) of the association of pre-conditioning and post-conditioning with
      Sevoflurane (AVH) sedation administered during and after scheduled surgery for valve
      replacement, via sternotomy or thoracotomy compared with total intravenous anaesthesia with
      Propofol.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2015</start_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Levels of troponin</measure>
    <time_frame>Change at Hour 6, Hour 12, Hour 24, Hour 48 compared with baseline level</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">82</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Sevoflurane Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>total anaesthesia and postoperative inhaled sedation with Sevoflurane</intervention_name>
    <arm_group_label>Sevoflurane Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>total intravenous anaesthesia with Propofol.</intervention_name>
    <arm_group_label>Propofol Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have provided informed written consent.

          -  Aortic valve replacement via sternotomy or thoracotomy, under Cardiopulmonary bypass
             (CPB).

          -  Anterograde cardioplegia with cold blood

        Exclusion Criteria:

          -  Adults under guardianship.

          -  Patients without national health insurance cover.

          -  Epileptics.

          -  Heart grafted patients.

          -  Patients under 18 years and pregnant or beast-feeding women.

          -  Aortic dissections and vascular surgery.

          -  Contra-indications to treatment with Sevoflurane: hypersensitivity to halogen-based
             anaesthetic agents, myopathy, personal or family history of malignant hyperthermia,
             hyper-eosinophilia, liver disease, icterus or unexplained fever after anaesthesia
             with a halogen-based anaesthetic agent

          -  Contra-indications to treatment with Propofol: known hypersensitivity to propofol or
             one of the constituents of the specific form used, hypersensitivity to peanuts or
             soja.

          -  pre-operative LVEF&lt;35%.

          -  Coronary artery bypass graft alone or associated.

          -  Mitral valve replacements.

          -  Warm cardioplegia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Claude GIRARD</last_name>
    <phone>3.80.29.35.28</phone>
    <phone_ext>33</phone_ext>
    <email>claude.girard@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claude GIRARD</last_name>
      <phone>3.80.29.35.28</phone>
      <phone_ext>33</phone_ext>
      <email>claude.girard@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>August 1, 2016</lastchanged_date>
  <firstreceived_date>July 28, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
